{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T06:40:23Z","timestamp":1784875223492,"version":"3.55.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T00:00:00Z","timestamp":1751068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T00:00:00Z","timestamp":1751068800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosurg Rev"],"DOI":"10.1007\/s10143-025-03672-1","type":"journal-article","created":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T22:41:13Z","timestamp":1751064073000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Does duration of nimodipine therapy impact outcome in aneurysmal subarachnoid hemorrhage: systematic review and meta-analysis"],"prefix":"10.1007","volume":"48","author":[{"given":"Spencer","family":"Oslin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilson","family":"Hoyt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherwin","family":"Tavakol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakeem","family":"Shakir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyian","family":"Jen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Graffeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,28]]},"reference":[{"issue":"2","key":"3672_CR1","doi-asserted-by":"publisher","first-page":"203","DOI":"10.5811\/westjem.2019.1.37352","volume":"20","author":"E Marcolini","year":"2019","unstructured":"Marcolini E, Hine J (2019) Approach to the Diagnosis and Management of Subarachnoid Hemorrhage. West J Emerg Med 20(2):203\u2013211. https:\/\/doi.org\/10.5811\/westjem.2019.1.37352","journal-title":"West J Emerg Med"},{"issue":"9","key":"3672_CR2","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s11910-021-01136-9","volume":"21","author":"ML Osgood","year":"2021","unstructured":"Osgood ML (2021) Aneurysmal subarachnoid hemorrhage: review of the pathophysiology and management strategies. Curr Neurol Neurosci Rep 21(9):50. https:\/\/doi.org\/10.1007\/s11910-021-01136-9","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"5","key":"3672_CR3","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1001\/jamaneurol.2019.0006","volume":"76","author":"N Etminan","year":"2019","unstructured":"Etminan N, Chang HS, Hackenberg K et al (2019) Worldwide incidence of aneurysmal subarachnoid hemorrhage according to region, time period, blood pressure, and smoking prevalence in the population: a systematic review and meta-analysis. JAMA Neurol 76(5):588\u2013597. https:\/\/doi.org\/10.1001\/jamaneurol.2019.0006","journal-title":"JAMA Neurol"},{"issue":"6","key":"3672_CR4","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1227\/01.neu.0000306090.30517.ae","volume":"61","author":"AM Shea","year":"2007","unstructured":"Shea AM, Reed SD, Curtis LH, Alexander MJ, Villani JJ, Schulman KA (2007) Characteristics of nontraumatic subarachnoid hemorrhage in the United States in 2003. Neurosurgery. 61(6):1131\u20131137. https:\/\/doi.org\/10.1227\/01.neu.0000306090.30517.ae","journal-title":"Neurosurgery."},{"issue":"3","key":"3672_CR5","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1097\/00006123-199609000-00001","volume":"39","author":"TH Schwartz","year":"1996","unstructured":"Schwartz TH, Solomon RA (1996) Perimesencephalic nonaneurysmal subarachnoid hemorrhage: review of the literature. Neurosurgery. 39(3):433\u2013440. https:\/\/doi.org\/10.1097\/00006123-199609000-00001","journal-title":"Neurosurgery."},{"issue":"2","key":"3672_CR6","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s10143-019-01096-2","volume":"43","author":"F Ikawa","year":"2020","unstructured":"Ikawa F, Michihata N, Matsushige T et al (2020) In-hospital mortality and poor outcome after surgical clipping and endovascular coiling for aneurysmal subarachnoid hemorrhage using nationwide databases: a systematic review and meta-analysis. Neurosurg Rev 43(2):655\u2013667. https:\/\/doi.org\/10.1007\/s10143-019-01096-2","journal-title":"Neurosurg Rev"},{"issue":"11 Pt 2","key":"3672_CR7","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1177\/0003319790041011014","volume":"41","author":"HP Adams","year":"1990","unstructured":"Adams HP (1990) Calcium antagonists in the management of patients with aneurysmal subarachnoid hemorrhage: a review. Angiology 41(11 Pt 2):1010\u20131016","journal-title":"Angiology"},{"issue":"3","key":"3672_CR8","doi-asserted-by":"publisher","first-page":"CD000277","DOI":"10.1002\/14651858.CD000277.pub3","volume":"2007","author":"SM Dorhout Mees","year":"2007","unstructured":"Dorhout Mees SM, Rinkel GJE, Feigin VL et al (2007) Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev 2007(3):CD000277. https:\/\/doi.org\/10.1002\/14651858.CD000277.pub3","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"3672_CR9","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s10571-014-0110-5","volume":"35","author":"J Koskim\u00e4ki","year":"2015","unstructured":"Koskim\u00e4ki J, Matsui N, Umemori J, Rantam\u00e4ki T, Castr\u00e9n E (2015) Nimodipine Activates TrkB Neurotrophin Receptors and Induces Neuroplastic and Neuroprotective Signaling Events in the Mouse Hippocampus and Prefrontal Cortex. Cell Mol Neurobiol 35(2):189\u2013196. https:\/\/doi.org\/10.1007\/s10571-014-0110-5","journal-title":"Cell Mol Neurobiol"},{"issue":"4","key":"3672_CR10","doi-asserted-by":"publisher","first-page":"505","DOI":"10.3171\/jns.1988.68.4.0505","volume":"68","author":"KC Petruk","year":"1988","unstructured":"Petruk KC, West M, Mohr G et al (1988) Nimodipine treatment in poor-grade aneurysm patients: Results of a multicenter double-blind placebo-controlled trial. J Neurosurg 68(4):505\u2013517. https:\/\/doi.org\/10.3171\/jns.1988.68.4.0505","journal-title":"J Neurosurg"},{"issue":"4","key":"3672_CR11","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1212\/wnl.50.4.876","volume":"50","author":"VL Feigin","year":"1998","unstructured":"Feigin VL, Rinkel GJ, Algra A, Vermeulen M, van Gijn J (1998) Calcium antagonists in patients with aneurysmal subarachnoid hemorrhage: a systematic review. Neurology 50(4):876\u2013883. https:\/\/doi.org\/10.1212\/wnl.50.4.876","journal-title":"Neurology"},{"issue":"Suppl 1","key":"3672_CR12","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1055\/s-2008-1054111","volume":"28","author":"MR Gaab","year":"1985","unstructured":"Gaab MR, Haubitz I, Brawanski A, Korn A, Czech T (1985) Acute effects of nimodipine on the cerebral blood flow and intracranial pressure. Neurochirurgia (Stuttg) 28(Suppl 1):93\u201399. https:\/\/doi.org\/10.1055\/s-2008-1054111","journal-title":"Neurochirurgia (Stuttg)"},{"issue":"11","key":"3672_CR13","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1056\/NEJM198303173081103","volume":"308","author":"GS Allen","year":"1983","unstructured":"Allen GS, Ahn HS, Preziosi TJ et al (1983) Cerebral arterial spasm\u2013a controlled trial of nimodipine in patients with subarachnoid hemorrhage. N Engl J Med 308(11):619\u2013624. https:\/\/doi.org\/10.1056\/NEJM198303173081103","journal-title":"N Engl J Med"},{"issue":"2","key":"3672_CR14","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s12028-011-9605-9","volume":"15","author":"MN Diringer","year":"2011","unstructured":"Diringer MN, Bleck TP, Claude Hemphill J et al (2011) Critical Care Management of Patients Following Aneurysmal Subarachnoid Hemorrhage: Recommendations from the Neurocritical Care Society\u2019s Multidisciplinary Consensus Conference. Neurocrit Care 15(2):211. https:\/\/doi.org\/10.1007\/s12028-011-9605-9","journal-title":"Neurocrit Care"},{"key":"3672_CR15","doi-asserted-by":"publisher","first-page":"106299","DOI":"10.1016\/j.clineuro.2020.106299","volume":"200","author":"JD Sokolowski","year":"2021","unstructured":"Sokolowski JD, Chen CJ, Soldozy S et al (2021) Nimodipine after aneurysmal subarachnoid hemorrhage: Fourteen-day course for patients that meet criteria for early hospital discharge. Clin Neurol Neurosurg 200:106299. https:\/\/doi.org\/10.1016\/j.clineuro.2020.106299","journal-title":"Clin Neurol Neurosurg"},{"issue":"9","key":"3672_CR16","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1177\/1060028016653138","volume":"50","author":"S Cho","year":"2016","unstructured":"Cho S, Bales J, Tran TK, Korab G, Khandelwal N, Joffe AM (2016) Effects of 14 Versus 21 Days of Nimodipine therapy on neurological outcomes in aneurysmal subarachnoid hemorrhage patients. Ann Pharmacother 50(9):718\u2013724. https:\/\/doi.org\/10.1177\/1060028016653138","journal-title":"Ann Pharmacother"},{"issue":"1","key":"3672_CR17","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s12028-015-0230-x","volume":"25","author":"N Sandow","year":"2016","unstructured":"Sandow N, Diesing D, Sarrafzadeh A, Vajkoczy P, Wolf S (2016) Nimodipine dose reductions in the treatment of patients with aneurysmal subarachnoid hemorrhage. Neurocrit Care 25(1):29\u201339. https:\/\/doi.org\/10.1007\/s12028-015-0230-x","journal-title":"Neurocrit Care"},{"issue":"1","key":"3672_CR18","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s10143-023-02273-0","volume":"47","author":"C Ditz","year":"2024","unstructured":"Ditz C, Matone MV, Schwachenwald B, K\u00fcchler J (2024) Risks of nimodipine dose reduction during the high-risk period for delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. Neurosurg Rev 47(1):37. https:\/\/doi.org\/10.1007\/s10143-023-02273-0","journal-title":"Neurosurg Rev"},{"key":"3672_CR19","unstructured":"Viechtbauer W (n.d.) metafor: Meta-analysis package for R. Published online March 28, 2024. https:\/\/cran.r-project.org\/web\/packages\/metafor\/index.html.\u00a0Accessed\u00a012 June 2024"},{"issue":"3","key":"3672_CR20","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1093\/neuros\/nyaa027","volume":"87","author":"VM Lu","year":"2020","unstructured":"Lu VM, Graffeo CS, Perry A et al (2020) Pearls for interpreting neurosurgical systematic reviews and meta-analyses: lessons from a collaborative effort. Neurosurgery 87(3):435\u2013441. https:\/\/doi.org\/10.1093\/neuros\/nyaa027","journal-title":"Neurosurgery"},{"issue":"3","key":"3672_CR21","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1007\/s11121-016-0643-6","volume":"18","author":"K Chen","year":"2017","unstructured":"Chen K, Cheng Y, Berkout O, Lindhiem O (2017) Analyzing proportion scores as outcomes for prevention trials: a statistical primer. Prev Sci Off J Soc Prev Res 18(3):312\u2013321. https:\/\/doi.org\/10.1007\/s11121-016-0643-6","journal-title":"Prev Sci Off J Soc Prev Res"},{"issue":"1","key":"3672_CR22","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1007\/s10143-024-02690-9","volume":"47","author":"SJ Oslin","year":"2024","unstructured":"Oslin SJ, Lu VM, Graffeo CS (2024) Systematic reviews and meta-analyses in the cerebrovascular space: essential domains for readers. Neurosurg Rev 47(1):454. https:\/\/doi.org\/10.1007\/s10143-024-02690-9","journal-title":"Neurosurg Rev"},{"key":"3672_CR23","doi-asserted-by":"publisher","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC, et al (2016) ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 4919. https:\/\/doi.org\/10.1136\/bmj.i4919","DOI":"10.1136\/bmj.i4919"},{"issue":"1","key":"3672_CR24","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1161\/STROKEAHA.116.014250","volume":"48","author":"D H\u00e4nggi","year":"2017","unstructured":"H\u00e4nggi D, Etminan N, Aldrich F et al (2017) Randomized, open-label, phase 1\/2a study to determine the maximum tolerated dose of intraventricular sustained release nimodipine for subarachnoid hemorrhage (NEWTON [nimodipine microparticles to enhance recovery while reducing toxicity after subarachnoid hemorrhage]). Stroke 48(1):145\u2013151. https:\/\/doi.org\/10.1161\/STROKEAHA.116.014250","journal-title":"Stroke"},{"key":"3672_CR25","doi-asserted-by":"publisher","unstructured":"Garc\u00eda-Pastor C, Navarro-Garcia de Llano JP, Balc\u00e1zar-Padr\u00f3n JC, et al (2022) Neuroprotective effect of dapsone in patients with aneurysmal subarachnoid hemorrhage: a prospective, randomized, double-blind, placebo-controlled clinical trial. Neurosurg Focus. 52(3):E12. https:\/\/doi.org\/10.3171\/2021.12.FOCUS21663","DOI":"10.3171\/2021.12.FOCUS21663"},{"issue":"2","key":"3672_CR26","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1097\/00008506-200604000-00009","volume":"18","author":"GKC Wong","year":"2006","unstructured":"Wong GKC, Chan MTV, Boet R, Poon WS, Gin T (2006) Intravenous magnesium sulfate after aneurysmal subarachnoid hemorrhage: a prospective randomized pilot study. J Neurosurg Anesthesiol 18(2):142\u2013148","journal-title":"J Neurosurg Anesthesiol"},{"issue":"suppl K","key":"3672_CR27","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/eurheartj\/8.suppl_K.41","volume":"8","author":"G Neil-Dwyer","year":"1987","unstructured":"Neil-Dwyer G, Mee E, Dorrance D, Lowe D (1987) Early intervention with nimodipine in subarachnoid haemorrhage. Eur Heart J 8(suppl K):41\u201347. https:\/\/doi.org\/10.1093\/eurheartj\/8.suppl_K.41","journal-title":"Eur Heart J"},{"issue":"9","key":"3672_CR28","doi-asserted-by":"publisher","first-page":"421","DOI":"10.2176\/nmc.46.421","volume":"46","author":"J Zhao","year":"2006","unstructured":"Zhao J, Zhou D, Guo J et al (2006) Effect of fasudil hydrochloride, a protein kinase inhibitor, on cerebral vasospasm and delayed cerebral ischemic symptoms after aneurysmal subarachnoid hemorrhage-results of a randomized trial of fasudil hydrochloride versus nimodipine-: \u2014results of a randomized trial of fasudil hydrochloride versus nimodipine\u2014. Neurol Med Chir (Tokyo) 46(9):421\u2013428. https:\/\/doi.org\/10.2176\/nmc.46.421","journal-title":"Neurol Med Chir (Tokyo)"},{"issue":"1","key":"3672_CR29","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3171\/2008.7.JNS08178","volume":"110","author":"E Kronvall","year":"2009","unstructured":"Kronvall E, Undr\u00e9n P, Romner B, S\u00e4veland H, Cronqvist M, Nilsson OG (2009) Nimodipine in aneurysmal subarachnoid hemorrhage: a randomized study of intravenous or peroral administration: Clinical article. J Neurosurg 110(1):58\u201363","journal-title":"J Neurosurg"},{"issue":"1\u20132","key":"3672_CR30","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.wneu.2011.09.030","volume":"78","author":"V Soppi","year":"2012","unstructured":"Soppi V, Karamanakos PN, Koivisto T et al (2012) A Randomized Outcome Study of Enteral versus Intravenous Nimodipine in 171 Patients After Acute Aneurysmal Subarachnoid Hemorrhage. World Neurosurg 78(1\u20132):101\u2013109. https:\/\/doi.org\/10.1016\/j.wneu.2011.09.030","journal-title":"World Neurosurg"},{"issue":"3","key":"3672_CR31","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1017\/s031716710003403x","volume":"25","author":"JM Findlay","year":"1998","unstructured":"Findlay JM, Deagle GM (1998) Causes of morbidity and mortality following intracranial aneurysm rupture. Can J Neurol Sci J Can Sci Neurol 25(3):209\u2013215. https:\/\/doi.org\/10.1017\/s031716710003403x","journal-title":"Can J Neurol Sci J Can Sci Neurol"},{"key":"3672_CR32","doi-asserted-by":"publisher","unstructured":"Carlson AP, H\u00e4nggi D, Wong GK, et al (2020) Single-Dose Intraventricular Nimodipine Microparticles Versus Oral Nimodipine for Aneurysmal Subarachnoid Hemorrhage. Stroke 00392499. 51(4):1142\u20131149. https:\/\/doi.org\/10.1161\/STROKEAHA.119.027396","DOI":"10.1161\/STROKEAHA.119.027396"},{"issue":"3","key":"3672_CR33","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1097\/00006123-199003000-00013","volume":"26","author":"JM Gilsbach","year":"1990","unstructured":"Gilsbach JM, Reulen HJ, Ljunggren B et al (1990) Early aneurysm surgery and preventive therapy with intravenously administered nimodipine: a multicenter, double-blind, dose-comparison study. Neurosurgery 26(3):458\u2013464. https:\/\/doi.org\/10.1097\/00006123-199003000-00013","journal-title":"Neurosurgery"},{"issue":"1","key":"3672_CR34","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3171\/jns.1991.74.1.0014","volume":"74","author":"J Ohman","year":"1991","unstructured":"Ohman J, Servo A, Heiskanen O (1991) Risks factors for cerebral infarction in good-grade patients after aneurysmal subarachnoid hemorrhage and surgery: a prospective study. J Neurosurg 74(1):14\u201320. https:\/\/doi.org\/10.3171\/jns.1991.74.1.0014","journal-title":"J Neurosurg"},{"issue":"6674","key":"3672_CR35","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1136\/bmj.298.6674.636","volume":"298","author":"JD Pickard","year":"1989","unstructured":"Pickard JD, Murray GD, Illingworth R et al (1989) Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. BMJ 298(6674):636\u2013642. https:\/\/doi.org\/10.1136\/bmj.298.6674.636","journal-title":"BMJ"},{"issue":"3","key":"3672_CR36","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1007\/s12028-022-01493-4","volume":"36","author":"F Geraldini","year":"2022","unstructured":"Geraldini F, De Cassai A, Diana P et al (2022) A comparison between enteral and intravenous nimodipine in subarachnoid hemorrhage: a systematic review and network meta-analysis. Neurocrit Care 36(3):1071\u20131079. https:\/\/doi.org\/10.1007\/s12028-022-01493-4","journal-title":"Neurocrit Care"},{"issue":"1","key":"3672_CR37","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/978-3-7091-4088-8_2","volume":"28","author":"G Teasdale","year":"1979","unstructured":"Teasdale G, Murray G, Parker L, Jennett B (1979) Adding up the Glasgow Coma Score. Acta Neurochir Suppl (Wien) 28(1):13\u201316. https:\/\/doi.org\/10.1007\/978-3-7091-4088-8_2","journal-title":"Acta Neurochir Suppl (Wien)"},{"issue":"1","key":"3672_CR38","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3171\/jns.1968.28.1.0014","volume":"28","author":"WE Hunt","year":"1968","unstructured":"Hunt WE, Hess RM (1968) Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg 28(1):14\u201320. https:\/\/doi.org\/10.3171\/jns.1968.28.1.0014","journal-title":"J Neurosurg"},{"issue":"9","key":"3672_CR39","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1161\/hs0901.095677","volume":"32","author":"J Claassen","year":"2001","unstructured":"Claassen J, Bernardini GL, Kreiter K et al (2001) Effect of cisternal and ventricular blood on risk of delayed cerebral ischemia after subarachnoid hemorrhage: the Fisher scale revisited. Stroke 32(9):2012\u20132020. https:\/\/doi.org\/10.1161\/hs0901.095677","journal-title":"Stroke"},{"key":"3672_CR40","doi-asserted-by":"publisher","first-page":"e100","DOI":"10.1016\/j.wneu.2017.10.089","volume":"110","author":"K Rumalla","year":"2018","unstructured":"Rumalla K, Smith KA, Arnold PM, Mittal MK (2018) Subarachnoid hemorrhage and readmissions: national rates, causes, risk factors, and outcomes in 16,001 hospitalized patients. World Neurosurg 110:e100\u2013e111. https:\/\/doi.org\/10.1016\/j.wneu.2017.10.089","journal-title":"World Neurosurg"},{"issue":"2","key":"3672_CR41","first-page":"120","volume":"6","author":"A Ciurea","year":"2013","unstructured":"Ciurea A, Palade C, Voinescu D, Nica D (2013) Subarachnoid hemorrhage and cerebral vasospasm \u2013 Literature review. J Med Life 6(2):120\u2013125","journal-title":"J Med Life"},{"issue":"6","key":"3672_CR42","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1161\/STR.0b013e3182587839","volume":"43","author":"ES Connolly","year":"2012","unstructured":"Connolly ES, Rabinstein AA, Carhuapoma JR et al (2012) Guidelines for the management of aneurysmal subarachnoid hemorrhage: A guideline for healthcare professionals from the american heart association\/american stroke association. Stroke 43(6):1711\u20131737. https:\/\/doi.org\/10.1161\/STR.0b013e3182587839","journal-title":"Stroke"},{"issue":"1","key":"3672_CR43","doi-asserted-by":"publisher","first-page":"14","DOI":"10.5455\/aim.2017.25.14-18","volume":"25","author":"J Djelilovic-Vranic","year":"2017","unstructured":"Djelilovic-Vranic J, Basic-Kes V, Tiric-Campara M, Djozic E, Kulenovic J (2017) Follow-up of Vasospasm by Transcranial Doppler Sonography (TCD) in Subarachnoid Hemorrhage (SAH). Acta Inform Medica AIM J Soc Med Inform Bosnia Herzeg Cas Drustva Za Med Inform BiH 25(1):14\u201318. https:\/\/doi.org\/10.5455\/aim.2017.25.14-18","journal-title":"Acta Inform Medica AIM J Soc Med Inform Bosnia Herzeg Cas Drustva Za Med Inform BiH"},{"issue":"7","key":"3672_CR44","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.3390\/jcm11072011","volume":"11","author":"H Merkel","year":"2022","unstructured":"Merkel H, Lindner D, Gaber K et al (2022) Standardized classification of cerebral vasospasm after subarachnoid hemorrhage by digital subtraction angiography. J Clin Med 11(7):2011. https:\/\/doi.org\/10.3390\/jcm11072011","journal-title":"J Clin Med"},{"issue":"4","key":"3672_CR45","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3109\/02699059309034957","volume":"7","author":"SI Anderson","year":"1993","unstructured":"Anderson SI, Housley AM, Jones PA, Slattery J, Miller JD (1993) Glasgow Outcome Scale: an inter-rater reliability study. Brain Inj 7(4):309\u2013317. https:\/\/doi.org\/10.3109\/02699059309034957","journal-title":"Brain Inj"},{"key":"3672_CR46","doi-asserted-by":"publisher","unstructured":"Braddom\u2019s Physical Medicine and Rehabilitation. Elsevier; 2021. https:\/\/doi.org\/10.1016\/C2017-0-03586-3","DOI":"10.1016\/C2017-0-03586-3"}],"container-title":["Neurosurgical Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-025-03672-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10143-025-03672-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-025-03672-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T04:15:01Z","timestamp":1772079301000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10143-025-03672-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,28]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3672"],"URL":"https:\/\/doi.org\/10.1007\/s10143-025-03672-1","relation":{},"ISSN":["1437-2320"],"issn-type":[{"value":"1437-2320","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,28]]},"assertion":[{"value":"2 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This manuscript has not been published elsewhere nor is under consideration by another journal.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This is a Systematic Review with Meta-Analysis no ethical approval is required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"A PRISMA 2020 compliant review with completed checklist.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Reporting checklist"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"531"}}